Phase Genomics

Phase Genomics' mission is to help scientists make breakthrough discoveries by providing the most complete, accurate, detailed genomes.

Launch date

Feb 2015

Employees

Market cap

Enterprise valuation

Seattle Washington (HQ)

Date	Investors	Amount	Round
-	Congruent Ventures Catapult VC Washington Research Foundation WRF Capital Sahsen Ventures	N/A	-
Jun 2018	National Institutes of Health	$1.5m	Grant
Feb 2019	Bill & Melinda Gates Foundation	$200k	Grant
Jan 2020	National Institute for Allergy and Infectious Diseases	$1.5m	Grant
Sep 2020	National Institutes of Health	$3.9m	Grant
Feb 2021	National Institute for Allergy and Infectious Diseases	$1.7m	Grant
Jun 2022*	National Institute for Allergy and Infectious Diseases Bill & Melinda Gates Foundation	$5.5m	Grant
Apr 2023*	N/A	$3.3m	Debt
Apr 2023*	N/A	$3.3m	Early VC
Aug 2023*	National Cancer Institute (NCI) Andy Hill Cancer Research Endowment (CARE) Fund	$2.5m	Grant
Mar 2024*	Bill & Melinda Gates Foundation	$1.5m	Grant
Total Funding		€20.5m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Phase Genomics